Prosecution Insights
Last updated: May 29, 2026

Roche Sequencing Solutions Inc.

19 pending office actions • 11 art units • 16 examiners • 0 of 19 (0%) have an AI response strategy ready • 26 patents granted in the last 365 days

Portfolio Summary

19
Total Pending OAs
12
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

13
Overdue
0
Due this week
3
Due this month
3
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (13)Due ≤ 30 days (3)Due ≤ 60 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (5%)
10
Medium (53%)
2
Easy (11%)
6
Unknown (32%)

Rejection Statute Mix

BucketCases
§101 only1 (5%)
§103 only9 (47%)
§102 only1 (5%)
§112 only2 (11%)
No statute on record6 (32%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RILEY, JEZIA 3 83.2% +6.9%
SISSON, BRADLEY L 2 19.6% +21.0%
COHEN, BRIAN W 1 54.2% +47.3%
WALLENHORST, MAUREEN 1 79.0% +5.3%
GRAY, JESSICA 1 0.0% +0.0%
GAMBLE JR, RANDALL LEE 1 48.3% +24.7%
BUNKER, AMY M 1 29.2% +46.5%
BOESEN, CHRISTIAN C 1 75.4% +21.5%
CASH, KAILEY ELIZABETH 1 28.6% +48.9%
KUMAR, SRILAKSHMI K 1 55.4% +15.6%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18000699 METHODS AND COMPOSITIONS FOR DETECTING STRUCTURAL REARRANGEMENTS IN A GENOME RILEY, JEZIA 36d overdue
18041348 NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSTIVIELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME RILEY, JEZIA 13d
17757527 METHODS OF SEQUENCING BY SYNTHESIS USING A CONSECUTIVE LABELING SCHEME RILEY, JEZIA 33d

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17995323 A METHOD OF DETECTING STRUCTURAL REARRANGEMENTS IN A GENOME CASH, KAILEY ELIZABETH 121d overdue
18012607 SPATIAL ANALYSIS OF MULTIPLE TARGETS IN TISSUE SAMPLES GRAY, JESSICA 66d overdue
17595263 DEVICES AND METHODS FOR SAMPLE ANALYSIS SISSON, BRADLEY L 46d overdue
17352087 IDENTIFICATION OF GLOBAL SEQUENCE FEATURES IN WHOLE GENOME SEQUENCE DATA FROM CIRCULATING NUCLEIC ACID AUGER, NOAH ANDREW 8d
18052337 MODULAR NUCLEIC ACID ADAPTERS BUNKER, AMY M 33d
17597760 SYSTEMS AND METHODS FOR CELL OF ORIGIN DETERMINATION FROM VARIANT CALLING DATA SISSON, BRADLEY L 42d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18058484 NANOPORE CELL WITH SEAMLESS WORKING ELECTRODE AND METHODS OF FORMING THE SAME GAMBLE JR, RANDALL LEE 138d overdue
17995323 A METHOD OF DETECTING STRUCTURAL REARRANGEMENTS IN A GENOME CASH, KAILEY ELIZABETH 121d overdue
17907362 DEVICES AND METHODS FOR SAMPLE ANALYSIS KUMAR, SRILAKSHMI K 53d overdue
17595263 DEVICES AND METHODS FOR SAMPLE ANALYSIS SISSON, BRADLEY L 46d overdue
17980393 PRIMER EXTENSION TARGET ENRICHMENT OF IMMUNE RECEPTOR SEQUENCES IN ALLOIMMUNE DISORDERS OF PREGNANCY BOESEN, CHRISTIAN C 11d overdue
18230398 NANOPORE FORMING METHOD AND USES THEREOF COHEN, BRIAN W 4d overdue
18052337 MODULAR NUCLEIC ACID ADAPTERS BUNKER, AMY M 33d
17597760 SYSTEMS AND METHODS FOR CELL OF ORIGIN DETERMINATION FROM VARIANT CALLING DATA SISSON, BRADLEY L 42d

Top Art Units

Art UnitApps
1681 3
1682 3
1684 3
1683 2
1687 2
1759 1
1797 1
1795 1
1700 1
1626 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18230398 NANOPORE FORMING METHOD AND USES THEREOF COHEN, BRIAN W 1759 Other Non-Final OA 4d overdue Pending Aug 04, 2023
18214232 TUNNELING JUNCTIONS FOR SEQUENCING WALLENHORST, MAUREEN 1797 §103 Non-Final OA 3d overdue Pending Jun 26, 2023
18041348 NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSTIVIELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME RILEY, JEZIA 1681 §103 Non-Final OA 13d Pending Feb 10, 2023
18012607 SPATIAL ANALYSIS OF MULTIPLE TARGETS IN TISSUE SAMPLES GRAY, JESSICA 1682 Other Non-Final OA 66d overdue Pending Dec 22, 2022
18000699 METHODS AND COMPOSITIONS FOR DETECTING STRUCTURAL REARRANGEMENTS IN A GENOME RILEY, JEZIA 1681 §112 Non-Final OA 36d overdue Pending Dec 05, 2022
18058484 NANOPORE CELL WITH SEAMLESS WORKING ELECTRODE AND METHODS OF FORMING THE SAME GAMBLE JR, RANDALL LEE 1795 §103 Final Rejection 138d overdue Pending Nov 23, 2022
18052337 MODULAR NUCLEIC ACID ADAPTERS BUNKER, AMY M 1684 §103 Final Rejection 33d Pending Nov 03, 2022
17980393 PRIMER EXTENSION TARGET ENRICHMENT OF IMMUNE RECEPTOR SEQUENCES IN ALLOIMMUNE DISORDERS OF PREGNANCY BOESEN, CHRISTIAN C 1684 Other Non-Final OA 11d overdue Pending Nov 03, 2022
17995323 A METHOD OF DETECTING STRUCTURAL REARRANGEMENTS IN A GENOME CASH, KAILEY ELIZABETH 1683 §103 Non-Final OA 121d overdue Pending Oct 03, 2022
17907362 DEVICES AND METHODS FOR SAMPLE ANALYSIS KUMAR, SRILAKSHMI K 1700 §103 Final Rejection 53d overdue Pending Sep 26, 2022
17934517 Methods for Identifying Multiple Epitopes in Selected Sub-Populations of Cells HAVLIN, ROBERT H 1626 Other Final Rejection 77d overdue Pending Sep 22, 2022
17905724 MAGNETIC SENSOR ARRAYS FOR NUCLEIC ACID SEQUENCING AND METHODS OF MAKING AND USING THEM LU, FRANK WEI MIN 1683 §102 Non-Final OA 59d overdue Pending Sep 06, 2022
17757527 METHODS OF SEQUENCING BY SYNTHESIS USING A CONSECUTIVE LABELING SCHEME RILEY, JEZIA 1681 §103 Final Rejection 33d Pending Jun 16, 2022
17805511 COMPUTING DEVICE WITH IMPROVED USER INTERFACE FOR INTERPRETING AND VISUALIZING DATA ANDERSON-FEARS, KEENAN NEIL 1687 §103 Non-Final OA 32d overdue Pending Jun 06, 2022
17597760 SYSTEMS AND METHODS FOR CELL OF ORIGIN DETERMINATION FROM VARIANT CALLING DATA SISSON, BRADLEY L 1682 §112 Final Rejection 42d Pending Jan 21, 2022
17561626 INCREASING DYNAMIC RANGE FOR IDENTIFYING MULTIPLE EPITOPES IN CELLS YOUNG, BRIAN ELLIS 1684 Other Non-Final OA 49d overdue Pending Dec 23, 2021
17595263 DEVICES AND METHODS FOR SAMPLE ANALYSIS SISSON, BRADLEY L 1682 Other Non-Final OA 46d overdue Pending Nov 12, 2021
17352087 IDENTIFICATION OF GLOBAL SEQUENCE FEATURES IN WHOLE GENOME SEQUENCE DATA FROM CIRCULATING NUCLEIC ACID AUGER, NOAH ANDREW 1687 §101 Final Rejection 8d Pending Jun 18, 2021
17346060 MONITORING MUTATIONS USING PRIOR KNOWLEDGE OF VARIANTS ROSSI, VY BUI 1685 §103 Non-Final OA 9d Pending Jun 11, 2021

Managing Roche Sequencing Solutions Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month